Investing in non-communicable disease prevention and management to advance the Sustainable Development Goals

Rachel Nugent, Melanie Y. Bertram, Stephen Jan, Louis W. Niessen, Franco Sassi, Dean T. Jamison, Eduardo González Pier, Robert Beaglehole

Research output: Contribution to journalReview articlepeer-review

Abstract

Reduction of the non-communicable disease (NCD) burden is a global development imperative. Sustainable Development Goal (SDG) 3 includes target 3·4 to reduce premature NCD mortality by a third by 2030. Progress on SDG target 3·4 will have a central role in determining the success of at least nine SDGs. A strengthened effort across multiple sectors with effective economic tools, such as price policies and insurance, is necessary. NCDs are heavily clustered in people with low socioeconomic status and are an important cause of medical impoverishment. They thereby exacerbate economic inequities within societies. As such, NCDs are a barrier to achieving SDG 1, SDG 2, SDG 4, SDG 5, and SDG 10. Productivity gains from preventing and managing NCDs will contribute to SDG 8. SDG 11 and SDG 12 offer clear opportunities to reduce the NCD burden and to create sustainable and healthy cities.

Original languageEnglish (US)
Pages (from-to)2029-2035
Number of pages7
JournalThe Lancet
Volume391
Issue number10134
DOIs
StatePublished - May 19 2018

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Investing in non-communicable disease prevention and management to advance the Sustainable Development Goals'. Together they form a unique fingerprint.

Cite this